Skip to main content
Journal cover image

Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial

Publication ,  Journal Article
Juraska, M; Early, AM; Li, L; Schaffner, SF; Lievens, M; Khorgade, A; Simpkins, B; Hejazi, NS; Benkeser, D; Wang, Q; Mercer, LD; Adjei, S ...
Published in: The Lancet Infectious Diseases
September 2024

Duke Scholars

Published In

The Lancet Infectious Diseases

DOI

ISSN

1473-3099

Publication Date

September 2024

Volume

24

Issue

9

Start / End Page

1025 / 1036

Publisher

Elsevier BV

Related Subject Headings

  • Microbiology
  • 4202 Epidemiology
  • 3207 Medical microbiology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1108 Medical Microbiology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Juraska, M., Early, A. M., Li, L., Schaffner, S. F., Lievens, M., Khorgade, A., … Neafsey, D. E. (2024). Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial. The Lancet Infectious Diseases, 24(9), 1025–1036. https://doi.org/10.1016/s1473-3099(24)00179-8
Juraska, Michal, Angela M. Early, Li Li, Stephen F. Schaffner, Marc Lievens, Akanksha Khorgade, Brian Simpkins, et al. “Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial.” The Lancet Infectious Diseases 24, no. 9 (September 2024): 1025–36. https://doi.org/10.1016/s1473-3099(24)00179-8.
Juraska M, Early AM, Li L, Schaffner SF, Lievens M, Khorgade A, Simpkins B, Hejazi NS, Benkeser D, Wang Q, Mercer LD, Adjei S, Agbenyega T, Anderson S, Ansong D, Bii DK, Buabeng PBY, English S, Fitzgerald N, Grimsby J, Kariuki SK, Otieno K, Roman F, Samuels AM, Westercamp N, Ockenhouse CF, Ofori-Anyinam O, Lee CK, MacInnis BL, Wirth DF, Gilbert PB, Neafsey DE. Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial. The Lancet Infectious Diseases. Elsevier BV; 2024 Sep;24(9):1025–1036.
Journal cover image

Published In

The Lancet Infectious Diseases

DOI

ISSN

1473-3099

Publication Date

September 2024

Volume

24

Issue

9

Start / End Page

1025 / 1036

Publisher

Elsevier BV

Related Subject Headings

  • Microbiology
  • 4202 Epidemiology
  • 3207 Medical microbiology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1108 Medical Microbiology
  • 1103 Clinical Sciences